These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 20230645)
21. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Aróstegui JI; Aldea A; Modesto C; Rua MJ; Argüelles F; González-Enseñat MA; Ramos E; Rius J; Plaza S; Vives J; Yagüe J Arthritis Rheum; 2004 Dec; 50(12):4045-50. PubMed ID: 15593220 [TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Lovell DJ; Bowyer SL; Solinger AM Arthritis Rheum; 2005 Apr; 52(4):1283-6. PubMed ID: 15818707 [TBL] [Abstract][Full Text] [Related]
23. CINCA syndrome with surgical intervention for valgus deformity and flexion contracture of the knee joint: A case report. Harada Y; Fukiage K; Nishikomori R; Suzuki S; Futami T Mod Rheumatol; 2017 Nov; 27(6):1098-1100. PubMed ID: 25867226 [TBL] [Abstract][Full Text] [Related]
24. [Bi-symptomatic CINCA syndrome with inaugural urticaria and major articular lesions]. Guillet G; Dupré D; Guillet MH; Prieur AM; Leroy JP; Sassolas B; Le Fur JM Ann Dermatol Venereol; 1999 Apr; 126(4):331-4. PubMed ID: 10421936 [TBL] [Abstract][Full Text] [Related]
25. Case Report: Efficacy, safety, and favorable long-term outcome of early treatment with IL-1 inhibitors in a patient with chronic infantile neurological cutaneous articular (CINCA) syndrome caused by NLRP3 mosaicism. Costagliola G; D'Elios S; Cappelli S; Massei F; Maestrini G; Beni A; Peroni D; Consolini R Front Pediatr; 2024; 12():1379616. PubMed ID: 38720945 [TBL] [Abstract][Full Text] [Related]
26. Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes. Bachove I; Chang C Open Access Rheumatol; 2014; 6():15-25. PubMed ID: 27790031 [TBL] [Abstract][Full Text] [Related]
27. Case Report: A neonatal case of cryopyrin-associated periodic syndrome with severe funisitis and neonatal asphyxia. Hayashida Y; Hatano M; Ito K; Sugie M; Kunieda J; Shimizu M; Morio T; Morioka C Front Pediatr; 2024; 12():1397412. PubMed ID: 38808101 [TBL] [Abstract][Full Text] [Related]
28. Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754 [TBL] [Abstract][Full Text] [Related]
29. Chronic infantile neurological cutaneous articular syndrome: CD10 over-expression in neutrophils is a possible key to the pathogenesis of the disease. Leone V; Presani G; Perticarari S; Tommasini A; Crovella S; Lenhardt A; Picco P; Lepore L Eur J Pediatr; 2003 Oct; 162(10):669-73. PubMed ID: 12928894 [TBL] [Abstract][Full Text] [Related]
30. The anesthetic management of children with neonatal-onset multi-system inflammatory disease. Lauro CF; Goldbach-Mansky R; Schmidt M; Quezado ZM Anesth Analg; 2007 Aug; 105(2):351-7. PubMed ID: 17646489 [TBL] [Abstract][Full Text] [Related]
31. [CINCA syndrome: a rare cause of papilledema. The case of homozygous twins]. Carzoli A; Maalouf T; Henckes O; Lemelle I; George JL; Angioi K J Fr Ophtalmol; 2010 Jan; 33(1):36-9. PubMed ID: 20005004 [TBL] [Abstract][Full Text] [Related]
32. Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene. Matsubayashi T; Sugiura H; Arai T; Oh-Ishi T; Inamo Y Acta Paediatr; 2006 Feb; 95(2):246-9. PubMed ID: 16449034 [TBL] [Abstract][Full Text] [Related]
33. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra. Rossi-Semerano L; Piram M; Chiaverini C; De Ricaud D; Smahi A; Koné-Paut I Pediatrics; 2013 Oct; 132(4):e1043-7. PubMed ID: 24019411 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts. Sarrabay G; Grandemange S; Touitou I Expert Rev Clin Immunol; 2015; 11(7):827-35. PubMed ID: 25979514 [TBL] [Abstract][Full Text] [Related]
35. [Exacerbation of skin lesions during fever in a patient with chronic infantile neurologic cutaneous articular (CINCA) syndrome]. Aboín-González S; Aldanondo-Fernández de la Mora I; García-Acebes CR; Carrillo-Gijón R; Harto-Castaño A; Jaén-Olasolo P Actas Dermosifiliogr; 2008; 99(6):481-4. PubMed ID: 18558058 [TBL] [Abstract][Full Text] [Related]
37. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years]. Idorn L; Vissing NH; Jensen L; Herlin T Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652 [TBL] [Abstract][Full Text] [Related]
38. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Prieur AM Clin Exp Rheumatol; 2001; 19(1):103-6. PubMed ID: 11247311 [TBL] [Abstract][Full Text] [Related]
39. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Saito M; Fujisawa A; Nishikomori R; Kambe N; Nakata-Hizume M; Yoshimoto M; Ohmori K; Okafuji I; Yoshioka T; Kusunoki T; Miyachi Y; Heike T; Nakahata T Arthritis Rheum; 2005 Nov; 52(11):3579-85. PubMed ID: 16255047 [TBL] [Abstract][Full Text] [Related]
40. Camptodactyly-arthropathy-coxavara-pericarditis syndrome in Saudi Arabia: clinical and molecular genetic findings in 22 patients. Albuhairan I; Al-Mayouf SM Semin Arthritis Rheum; 2013 Oct; 43(2):292-6. PubMed ID: 23290693 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]